Thyroid Eye Disease Following COVID-19 Vaccine in a Patient With a History Graves' Disease: A Case Report

Ophthalmic Plast Reconstr Surg. 2021 Nov-Dec;37(6):e221-e223. doi: 10.1097/IOP.0000000000002059.

Abstract

A 50-year-old woman with a history of controlled Graves' disease without clinical ophthalmopathy presents with 2 months of left more than right periorbital swelling and proptosis. Her eye symptoms and signs began 3 days following her second vaccination against the COVID-19 virus. Orbital imaging, elevated thyroid stimulating immunoglobulin, and negative systemic work up for other diseases were consistent with a diagnosis of active thyroid eye disease. The temporal relationship to her vaccination was likely consistent with autoimmune/inflammatory syndrome associated with adjuvants. Clinicians should remind patients of the symptoms and signs of thyroid eye disease and to seek appropriate medical and ophthalmic advice if they occur after the COVID-19 vaccine.

Publication types

  • Case Reports

MeSH terms

  • COVID-19 Vaccines
  • COVID-19*
  • Female
  • Graves Disease* / diagnosis
  • Graves Ophthalmopathy* / diagnosis
  • Graves Ophthalmopathy* / etiology
  • Humans
  • Middle Aged
  • SARS-CoV-2

Substances

  • COVID-19 Vaccines